BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 29179779)

  • 1. Evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines.
    Ghosh R; Oak N; Plon SE
    Genome Biol; 2017 Nov; 18(1):225. PubMed ID: 29179779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
    Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
    Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications and considerations for evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines.
    Bean LJH; Hegde MR
    Genome Med; 2017 Dec; 9(1):111. PubMed ID: 29254502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies.
    Amendola LM; Muenzen K; Biesecker LG; Bowling KM; Cooper GM; Dorschner MO; Driscoll C; Foreman AKM; Golden-Grant K; Greally JM; Hindorff L; Kanavy D; Jobanputra V; Johnston JJ; Kenny EE; McNulty S; Murali P; Ou J; Powell BC; Rehm HL; Rolf B; Roman TS; Van Ziffle J; Guha S; Abhyankar A; Crosslin D; Venner E; Yuan B; Zouk H; ; Jarvik GP
    Am J Hum Genet; 2020 Nov; 107(5):932-941. PubMed ID: 33108757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adapting ACMG/AMP sequence variant classification guidelines for single-gene copy number variants.
    Brandt T; Sack LM; Arjona D; Tan D; Mei H; Cui H; Gao H; Bean LJH; Ankala A; Del Gaudio D; Knight Johnson A; Vincent LM; Reavey C; Lai A; Richard G; Meck JM
    Genet Med; 2020 Feb; 22(2):336-344. PubMed ID: 31534211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines.
    Li Q; Wang K
    Am J Hum Genet; 2017 Feb; 100(2):267-280. PubMed ID: 28132688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposition of adjustments to the ACMG-AMP framework for the interpretation of MEN1 missense variants.
    Romanet P; Odou MF; North MO; Saveanu A; Coppin L; Pasmant E; Mohamed A; Goudet P; Borson-Chazot F; Calender A; Béroud C; Lévy N; Giraud S; Barlier A
    Hum Mutat; 2019 Jun; 40(6):661-674. PubMed ID: 30869828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ClinGen Pathogenicity Calculator: a configurable system for assessing pathogenicity of genetic variants.
    Patel RY; Shah N; Jackson AR; Ghosh R; Pawliczek P; Paithankar S; Baker A; Riehle K; Chen H; Milosavljevic S; Bizon C; Rynearson S; Nelson T; Jarvik GP; Rehm HL; Harrison SM; Azzariti D; Powell B; Babb L; Plon SE; Milosavljevic A;
    Genome Med; 2017 Jan; 9(1):3. PubMed ID: 28081714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework.
    Tavtigian SV; Greenblatt MS; Harrison SM; Nussbaum RL; Prabhu SA; Boucher KM; Biesecker LG;
    Genet Med; 2018 Sep; 20(9):1054-1060. PubMed ID: 29300386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-specific ACMG/AMP guidelines improve sequence variant interpretation for hearing loss.
    Patel MJ; DiStefano MT; Oza AM; Hughes MY; Wilcox EH; Hemphill SE; Cushman BJ; Grant AR; Siegert RK; Shen J; Chapin A; Boczek NJ; Schimmenti LA; Nara K; Kenna M; Azaiez H; Booth KT; Avraham KB; Kremer H; Griffith AJ; Rehm HL; Amr SS; Tayoun ANA;
    Genet Med; 2021 Nov; 23(11):2208-2212. PubMed ID: 34230634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants.
    Lee K; Krempely K; Roberts ME; Anderson MJ; Carneiro F; Chao E; Dixon K; Figueiredo J; Ghosh R; Huntsman D; Kaurah P; Kesserwan C; Landrith T; Li S; Mensenkamp AR; Oliveira C; Pardo C; Pesaran T; Richardson M; Slavin TP; Spurdle AB; Trapp M; Witkowski L; Yi CS; Zhang L; Plon SE; Schrader KA; Karam R
    Hum Mutat; 2018 Nov; 39(11):1553-1568. PubMed ID: 30311375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical laboratories collaborate to resolve differences in variant interpretations submitted to ClinVar.
    Harrison SM; Dolinsky JS; Knight Johnson AE; Pesaran T; Azzariti DR; Bale S; Chao EC; Das S; Vincent L; Rehm HL
    Genet Med; 2017 Oct; 19(10):1096-1104. PubMed ID: 28301460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of Specifications to the ACMG/AMP Variant Interpretation Guidelines.
    Harrison SM; Biesecker LG; Rehm HL
    Curr Protoc Hum Genet; 2019 Sep; 103(1):e93. PubMed ID: 31479589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and Considerations in Sequence Variant Interpretation for Mendelian Disorders.
    Kim YE; Ki CS; Jang MA
    Ann Lab Med; 2019 Sep; 39(5):421-429. PubMed ID: 31037860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene-level specification of the ACMG/AMP guidelines for sequence variant interpretation.
    Rivera-Muñoz EA; Milko LV; Harrison SM; Azzariti DR; Kurtz CL; Lee K; Mester JL; Weaver MA; Currey E; Craigen W; Eng C; Funke B; Hegde M; Hershberger RE; Mao R; Steiner RD; Vincent LM; Martin CL; Plon SE; Ramos E; Rehm HL; Watson M; Berg JS
    Hum Mutat; 2018 Nov; 39(11):1614-1622. PubMed ID: 30311389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adapting the ACMG/AMP variant classification framework: A perspective from the ClinGen Hemoglobinopathy Variant Curation Expert Panel.
    Kountouris P; Stephanou C; Lederer CW; Traeger-Synodinos J; Bento C; Harteveld CL; Fylaktou E; Koopmann TT; Halim-Fikri H; Michailidou K; Nfonsam LE; Waye JS; Zilfalil BA; Kleanthous M;
    Hum Mutat; 2022 Aug; 43(8):1089-1096. PubMed ID: 34510646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward automation of germline variant curation in clinical cancer genetics.
    Ravichandran V; Shameer Z; Kemel Y; Walsh M; Cadoo K; Lipkin S; Mandelker D; Zhang L; Stadler Z; Robson M; Offit K; Vijai J
    Genet Med; 2019 Sep; 21(9):2116-2125. PubMed ID: 30787465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guideline-based and bioinformatic reassessment of lesion-associated gene and variant pathogenicity in focal human epilepsies.
    Niestroj LM; Du J; Nothnagel M; May P; Palotie A; Daly MJ; Nürnberg P; Blümcke I; Lal D
    Epilepsia; 2018 Nov; 59(11):2145-2152. PubMed ID: 30341947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Frequency of Discordant Variant Classification in the Human Gene Mutation Database: A Comparison of the American College of Medical Genetics and Genomics Guidelines and ClinVar.
    Park KJ; Lee W; Chun S; Min WK
    Lab Med; 2021 May; 52(3):250-259. PubMed ID: 32926152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
    Richards S; Aziz N; Bale S; Bick D; Das S; Gastier-Foster J; Grody WW; Hegde M; Lyon E; Spector E; Voelkerding K; Rehm HL;
    Genet Med; 2015 May; 17(5):405-24. PubMed ID: 25741868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.